The increasing demand for controlled immunological study and therapeutic design has spurred significant progress in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using various expression systems, including microbial hosts, mammalian cell lines, and viral expressio